ANDA 85772, held by Watson Labs. Butabarbital Sodium.
As of Nov 16, 2026, ANDA 85772 (Butabarbital Sodium), held by Watson Labs, was first approved by FDA on Aug 24, 1977, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 24, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butabarbital Sodium30MG ยท tablet;oral | Butabarbital Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters